StockNow
Calendar
Log in
U.S. Markets

True Alpha reportedly flags Repligen (RGEN) as biotech buyout, potential USD 327 in takeout - unconfirmed

StockNow breaking-news AI analysis

True Alpha reportedly flagged Repligen as an unconfirmed biotech buyout candidate with a potential USD 327 takeout valuation.

1 stocks
RGENRepligen Corp$180.12Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

US President Trump posts "Russia has unfortunately lost control of its Diesel Oil Industry due to its War with Ukraine"

Geopolitics

US President Trump, to Fox TV, says very big things are going to be happening in the not-so-distant future on Iran

FOXAFOXFed

Fed's Goolsbee (2027 Voter) says that a mix of supply and demand pressures on inflation has more impact on PCE than destination